{"id":5519,"date":"2021-02-28T15:55:15","date_gmt":"2021-02-28T15:55:15","guid":{"rendered":"https:\/\/ring20researchsupport.co.uk\/?post_type=cause&#038;p=2630"},"modified":"2023-02-10T08:54:19","modified_gmt":"2023-02-10T08:54:19","slug":"covid-19-priority-vaccinations","status":"publish","type":"post","link":"https:\/\/ring20researchsupport.co.uk\/nb\/2021\/02\/covid-19-priority-vaccinations\/","title":{"rendered":"COVID-19 \u2013 prioritet for vaksinasjoner"},"content":{"rendered":"<h1>Personer med r(20)-syndrom (i Storbritannia)<\/h1>\n<p>Hos Ring20 har det kommet til v\u00e5r oppmerksomhet at enkelte personer diagnostisert med r(20)-syndrom ikke blir tilbudt covid-19-vaksinen som en del av <strong>prioritetsgruppe 6<\/strong> i Storbritannia. Dette ser ut til \u00e5 skyldes at fastlegene ikke klassifiserer personen som epilepsi i sin journal \u2013 selv om personen har en r(20)-diagnose og regelmessig foreskrives anti-anfallsmedisiner (ASM).<\/p>\n<p>Ring20 mistenker at dette skyldes manglende bevissthet om r(20) syndrom p\u00e5 vegne av fastlegene, men vi \u00f8nsker \u00e5 sikre at <strong>personer med r(20) syndrom (over 16 \u00e5r) tilbys en vaksinasjonsavtale som en del av den aktuelle prioriterte gruppen, som er deres rett<\/strong>.<\/p>\n<p>Hvis dette er situasjonen i Storbritannia, mistenker Ring20 at dette ogs\u00e5 kan skje i utlandet, selv om utrullingen av vaksine kanskje ikke er like avansert som i Storbritannia og prioriterte grupper kan variere fra land til land.<\/p>\n<blockquote><p><strong>Uttalelse fra Ring20 Medical Advisory Board<\/strong><\/p>\n<p>Personer med en r(20)-diagnose b\u00f8r ha registrert at r(20)-syndrom er en sjelden form for epileptisk encefalopati \u2013 og b\u00f8r f\u00e5 tilbud om covid-19-vaksinasjon sammen med alle andre personer som er diagnostisert med epilepsi.<\/p><\/blockquote>\n<h1>Foreldre\/omsorgspersoner til personer med r(20)-syndrom (i Storbritannia)<\/h1>\n<p>Som omsorgsperson for barnet ditt (uansett barnets alder, selv om det n\u00e5 er voksen), har foreldre\/omsorgspersoner til en person med r(20)-syndrom i Storbritannia rett til \u00e5 bli tilbudt en prioritert COVID-19-vaksinasjon, som en <strong>ul\u00f8nnet omsorgsperson<\/strong>. Du trenger ikke \u00e5 ha noen fordeler, f.eks. omsorgspenger, for \u00e5 kvalifisere deg som en <strong>ul\u00f8nnet omsorgsperson<\/strong>.<\/p>\n<p><strong>Bare be om \u00e5 registrere deg som ul\u00f8nnet omsorgsperson hos fastlegen din.<\/strong> Du vil ogs\u00e5 fremover f\u00e5 prioritert tilgang til en influensajab hvert \u00e5r som f\u00f8lge av at dette legges inn i din journal. Det kan v\u00e6re annen st\u00f8tte tilgjengelig for deg ogs\u00e5 i fremtiden; som fastlegen din skal varsle deg om. Mer informasjon finner du p\u00e5 <a href=\"https:\/\/contact.org.uk\/news-and-blogs\/the-latest-on-unpaid-carers-and-the-covid-19-vaccine\/\">Kontakt<\/a> nettsted. Takk til Kontakt veldedighet for \u00e5 dele denne informasjonen.<\/p>\n<p>Ring20 kan ikke kommentere situasjonen for pleiere utenfor Storbritannia som blir prioritert for en vaksine, men foresl\u00e5r at du unders\u00f8ker lokalt om det finnes en lignende ordning for deg.<\/p>","protected":false},"excerpt":{"rendered":"<p>Hos Ring20 har det kommet til v\u00e5r oppmerksomhet at enkelte personer diagnostisert med r(20)-syndrom ikke blir tilbudt COVID-19-vaksinen som en del av prioritetsgruppe 6 i Storbritannia. Dette ser ut til \u00e5 skyldes at fastlegene ikke klassifiserer personen som \u00e5 ha epilepsi i sin journal \u2013 selv om personen har en r(20)-diagnose og regelmessig foreskrives anti-anfallsmedisiner (ASM).<\/p>","protected":false},"author":3,"featured_media":5781,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[96],"tags":[],"class_list":["post-5519","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-covid-19"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>COVID-19 - priority for vaccinations - Ring20 Research and Support UK CIO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ring20researchsupport.co.uk\/nb\/2021\/02\/covid-19-priority-vaccinations\/\" \/>\n<meta property=\"og:locale\" content=\"nb_NO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"COVID-19 - priority for vaccinations - Ring20 Research and Support UK CIO\" \/>\n<meta property=\"og:description\" content=\"At Ring20, it has come to our attention that some individuals diagnosed with r(20) syndrome are not being offered the COVID-19 vaccine as part of priority group 6 within the UK. This appears to be due to GP&#039;s not classifying the individual as having epilepsy on their medical records - even though the individual has an r(20) diagnosis and is regularly prescribed anti-seizure medications (ASM&#039;s).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ring20researchsupport.co.uk\/nb\/2021\/02\/covid-19-priority-vaccinations\/\" \/>\n<meta property=\"og:site_name\" content=\"Ring20 Research and Support UK CIO\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-28T15:55:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-10T08:54:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2021\/02\/Copy-of-Copy-of-Untitled-4-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Alison\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skrevet av\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alison\" \/>\n\t<meta name=\"twitter:label2\" content=\"Ansl. lesetid\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2021\\\/02\\\/covid-19-priority-vaccinations\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2021\\\/02\\\/covid-19-priority-vaccinations\\\/\"},\"author\":{\"name\":\"Alison\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#\\\/schema\\\/person\\\/26816b7c1c7561b936befe247794dcac\"},\"headline\":\"COVID-19 &#8211; priority for vaccinations\",\"datePublished\":\"2021-02-28T15:55:15+00:00\",\"dateModified\":\"2023-02-10T08:54:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2021\\\/02\\\/covid-19-priority-vaccinations\\\/\"},\"wordCount\":384,\"publisher\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2021\\\/02\\\/covid-19-priority-vaccinations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/Copy-of-Copy-of-Untitled-4-1.png\",\"articleSection\":[\"COVID-19\"],\"inLanguage\":\"nb-NO\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2021\\\/02\\\/covid-19-priority-vaccinations\\\/\",\"url\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2021\\\/02\\\/covid-19-priority-vaccinations\\\/\",\"name\":\"COVID-19 - priority for vaccinations - Ring20 Research and Support UK CIO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2021\\\/02\\\/covid-19-priority-vaccinations\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2021\\\/02\\\/covid-19-priority-vaccinations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/Copy-of-Copy-of-Untitled-4-1.png\",\"datePublished\":\"2021-02-28T15:55:15+00:00\",\"dateModified\":\"2023-02-10T08:54:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2021\\\/02\\\/covid-19-priority-vaccinations\\\/#breadcrumb\"},\"inLanguage\":\"nb-NO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2021\\\/02\\\/covid-19-priority-vaccinations\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nb-NO\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2021\\\/02\\\/covid-19-priority-vaccinations\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/Copy-of-Copy-of-Untitled-4-1.png\",\"contentUrl\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/Copy-of-Copy-of-Untitled-4-1.png\",\"width\":300,\"height\":300},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2021\\\/02\\\/covid-19-priority-vaccinations\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"COVID-19 &#8211; priority for vaccinations\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#website\",\"url\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/\",\"name\":\"Ring20 Research and Support UK CIO\",\"description\":\"Promoting research, education and continuous support to end undiagnosed and misdiagnosed Ring20 epilepsy\",\"publisher\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nb-NO\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#organization\",\"name\":\"Ring20 Research and Support CIO\",\"url\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nb-NO\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Ring20_logo-high-resolution.jpg\",\"contentUrl\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Ring20_logo-high-resolution.jpg\",\"width\":2357,\"height\":666,\"caption\":\"Ring20 Research and Support CIO\"},\"image\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#\\\/schema\\\/person\\\/26816b7c1c7561b936befe247794dcac\",\"name\":\"Alison\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nb-NO\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ade8313c3cbccc4f3dab7d41f7722b149cb238832a224128ffac0ebf12935eaa?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ade8313c3cbccc4f3dab7d41f7722b149cb238832a224128ffac0ebf12935eaa?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ade8313c3cbccc4f3dab7d41f7722b149cb238832a224128ffac0ebf12935eaa?s=96&d=mm&r=g\",\"caption\":\"Alison\"},\"url\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/nb\\\/author\\\/alison\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"COVID-19 - priority for vaccinations - Ring20 Research and Support UK CIO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ring20researchsupport.co.uk\/nb\/2021\/02\/covid-19-priority-vaccinations\/","og_locale":"nb_NO","og_type":"article","og_title":"COVID-19 - priority for vaccinations - Ring20 Research and Support UK CIO","og_description":"At Ring20, it has come to our attention that some individuals diagnosed with r(20) syndrome are not being offered the COVID-19 vaccine as part of priority group 6 within the UK. This appears to be due to GP's not classifying the individual as having epilepsy on their medical records - even though the individual has an r(20) diagnosis and is regularly prescribed anti-seizure medications (ASM's).","og_url":"https:\/\/ring20researchsupport.co.uk\/nb\/2021\/02\/covid-19-priority-vaccinations\/","og_site_name":"Ring20 Research and Support UK CIO","article_published_time":"2021-02-28T15:55:15+00:00","article_modified_time":"2023-02-10T08:54:19+00:00","og_image":[{"width":300,"height":300,"url":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2021\/02\/Copy-of-Copy-of-Untitled-4-1.png","type":"image\/png"}],"author":"Alison","twitter_card":"summary_large_image","twitter_misc":{"Skrevet av":"Alison","Ansl. lesetid":"2 minutter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ring20researchsupport.co.uk\/2021\/02\/covid-19-priority-vaccinations\/#article","isPartOf":{"@id":"https:\/\/ring20researchsupport.co.uk\/2021\/02\/covid-19-priority-vaccinations\/"},"author":{"name":"Alison","@id":"https:\/\/ring20researchsupport.co.uk\/#\/schema\/person\/26816b7c1c7561b936befe247794dcac"},"headline":"COVID-19 &#8211; priority for vaccinations","datePublished":"2021-02-28T15:55:15+00:00","dateModified":"2023-02-10T08:54:19+00:00","mainEntityOfPage":{"@id":"https:\/\/ring20researchsupport.co.uk\/2021\/02\/covid-19-priority-vaccinations\/"},"wordCount":384,"publisher":{"@id":"https:\/\/ring20researchsupport.co.uk\/#organization"},"image":{"@id":"https:\/\/ring20researchsupport.co.uk\/2021\/02\/covid-19-priority-vaccinations\/#primaryimage"},"thumbnailUrl":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2021\/02\/Copy-of-Copy-of-Untitled-4-1.png","articleSection":["COVID-19"],"inLanguage":"nb-NO"},{"@type":"WebPage","@id":"https:\/\/ring20researchsupport.co.uk\/2021\/02\/covid-19-priority-vaccinations\/","url":"https:\/\/ring20researchsupport.co.uk\/2021\/02\/covid-19-priority-vaccinations\/","name":"COVID-19 - priority for vaccinations - Ring20 Research and Support UK CIO","isPartOf":{"@id":"https:\/\/ring20researchsupport.co.uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ring20researchsupport.co.uk\/2021\/02\/covid-19-priority-vaccinations\/#primaryimage"},"image":{"@id":"https:\/\/ring20researchsupport.co.uk\/2021\/02\/covid-19-priority-vaccinations\/#primaryimage"},"thumbnailUrl":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2021\/02\/Copy-of-Copy-of-Untitled-4-1.png","datePublished":"2021-02-28T15:55:15+00:00","dateModified":"2023-02-10T08:54:19+00:00","breadcrumb":{"@id":"https:\/\/ring20researchsupport.co.uk\/2021\/02\/covid-19-priority-vaccinations\/#breadcrumb"},"inLanguage":"nb-NO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ring20researchsupport.co.uk\/2021\/02\/covid-19-priority-vaccinations\/"]}]},{"@type":"ImageObject","inLanguage":"nb-NO","@id":"https:\/\/ring20researchsupport.co.uk\/2021\/02\/covid-19-priority-vaccinations\/#primaryimage","url":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2021\/02\/Copy-of-Copy-of-Untitled-4-1.png","contentUrl":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2021\/02\/Copy-of-Copy-of-Untitled-4-1.png","width":300,"height":300},{"@type":"BreadcrumbList","@id":"https:\/\/ring20researchsupport.co.uk\/2021\/02\/covid-19-priority-vaccinations\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ring20researchsupport.co.uk\/"},{"@type":"ListItem","position":2,"name":"COVID-19 &#8211; priority for vaccinations"}]},{"@type":"WebSite","@id":"https:\/\/ring20researchsupport.co.uk\/#website","url":"https:\/\/ring20researchsupport.co.uk\/","name":"Ring20 Research and Support UK CIO","description":"Fremme forskning, utdanning og kontinuerlig st\u00f8tte for \u00e5 f\u00e5 slutt p\u00e5 udiagnostisert og feildiagnostisert Ring20-epilepsi","publisher":{"@id":"https:\/\/ring20researchsupport.co.uk\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ring20researchsupport.co.uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nb-NO"},{"@type":"Organization","@id":"https:\/\/ring20researchsupport.co.uk\/#organization","name":"Ring20 Forskning og St\u00f8tte CIO","url":"https:\/\/ring20researchsupport.co.uk\/","logo":{"@type":"ImageObject","inLanguage":"nb-NO","@id":"https:\/\/ring20researchsupport.co.uk\/#\/schema\/logo\/image\/","url":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2021\/03\/Ring20_logo-high-resolution.jpg","contentUrl":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2021\/03\/Ring20_logo-high-resolution.jpg","width":2357,"height":666,"caption":"Ring20 Research and Support CIO"},"image":{"@id":"https:\/\/ring20researchsupport.co.uk\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ring20researchsupport.co.uk\/#\/schema\/person\/26816b7c1c7561b936befe247794dcac","name":"Alison","image":{"@type":"ImageObject","inLanguage":"nb-NO","@id":"https:\/\/secure.gravatar.com\/avatar\/ade8313c3cbccc4f3dab7d41f7722b149cb238832a224128ffac0ebf12935eaa?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ade8313c3cbccc4f3dab7d41f7722b149cb238832a224128ffac0ebf12935eaa?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ade8313c3cbccc4f3dab7d41f7722b149cb238832a224128ffac0ebf12935eaa?s=96&d=mm&r=g","caption":"Alison"},"url":"https:\/\/ring20researchsupport.co.uk\/nb\/author\/alison\/"}]}},"_links":{"self":[{"href":"https:\/\/ring20researchsupport.co.uk\/nb\/wp-json\/wp\/v2\/posts\/5519","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ring20researchsupport.co.uk\/nb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ring20researchsupport.co.uk\/nb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ring20researchsupport.co.uk\/nb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ring20researchsupport.co.uk\/nb\/wp-json\/wp\/v2\/comments?post=5519"}],"version-history":[{"count":1,"href":"https:\/\/ring20researchsupport.co.uk\/nb\/wp-json\/wp\/v2\/posts\/5519\/revisions"}],"predecessor-version":[{"id":10382,"href":"https:\/\/ring20researchsupport.co.uk\/nb\/wp-json\/wp\/v2\/posts\/5519\/revisions\/10382"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ring20researchsupport.co.uk\/nb\/wp-json\/wp\/v2\/media\/5781"}],"wp:attachment":[{"href":"https:\/\/ring20researchsupport.co.uk\/nb\/wp-json\/wp\/v2\/media?parent=5519"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ring20researchsupport.co.uk\/nb\/wp-json\/wp\/v2\/categories?post=5519"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ring20researchsupport.co.uk\/nb\/wp-json\/wp\/v2\/tags?post=5519"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}